FibroBiologics Inc.
Organization details
- Legal name
- FibroBiologics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FBLG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001958777
- EIN
- 86-3329066
Board of directors
-
Kathleen Hallisey Rubins · DirectorSince 2026
-
Leigh Steinberg · DirectorSince 2026
-
Matthew Link · DirectorSince 2024
-
Pete O'heeron · Director · CHIEF EXECUTIVE OFFICERSince 2024
-
Richard C. Cilento Jr. · DirectorSince 2024
-
Robert E. Hoffman · DirectorSince 2024
-
Stacy Ann Coen · DirectorSince 2024
-
Victoria Ninon Olivia Niklas · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 12, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.2%
-
98.8%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
TuHURA Biosciences Inc. Same sectorvia Robert E. Hoffman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $120,493
- 7 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Khoja Hamid Officer (Chief Scientific Officer) | Grant or award | +298,508 | $1.68 | $501,493 |
| Mar 4, 2026 | Khoja Hamid Officer (Chief Scientific Officer) | Open-market purchase | +30,000 | $0.38 | $11,400 |
| Mar 4, 2026 | Pete O'heeron Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | +15,872 | $0.38 | $6,031 |
| Mar 3, 2026 | Pete O'heeron Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | +18,200 | $0.41 | $7,462 |
| Mar 2, 2026 | Pete O'heeron Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | +17,428 | $0.35 | $6,100 |
| Mar 2, 2026 | Davis Jason Officer (Chief Financial Officer) | Open-market purchase | +70,000 | $0.41 | $28,700 |
| Feb 27, 2026 | GARCIA RUBEN A Officer (General Counsel) | Open-market purchase | +40,000 | $0.33 | $13,200 |
| Dec 11, 2025 | GARCIA RUBEN A Officer (General Counsel) | Open-market purchase | +140,000 | $0.34 | $47,600 |
| May 27, 2025 | Khoja Hamid Officer (Chief Scientific Officer) | Open-market purchase | +20,000 | $0.84 | $16,800 |
| Dec 9, 2024 | Pete O'heeron Director, Officer (Chief Executive Officer) | Gift | −100,000 | — | — |
| Dec 3, 2024 | Pete O'heeron Director, Officer (Chief Executive Officer) | Gift | −50,000 | — | — |
| Aug 12, 2024 | Pete O'heeron Director, Officer (Chief Executive Officer) | Open-market purchase | +8,500 | $1.91 | $16,235 |
| Aug 12, 2024 | Khoja Hamid Officer (Chief Scientific Officer) | Open-market purchase | +10,000 | $1.90 | $19,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about FibroBiologics Inc.
Who is the CEO of FibroBiologics Inc.?
Pete O'heeron has been FibroBiologics Inc.'s Chief Executive Officer since January 2024.
How many directors are on FibroBiologics Inc.'s board?
FibroBiologics Inc.'s board has 8 directors: Kathleen Hallisey Rubins, Leigh Steinberg, Matthew Link, Pete O'heeron, Richard C. Cilento Jr., Robert E. Hoffman, Stacy Ann Coen and Victoria Ninon Olivia Niklas.
Are FibroBiologics Inc. insiders buying or selling shares?
Over the last 12 months, FibroBiologics Inc. insiders bought $120,493 of shares in 7 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="fibrobiologics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.